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Two types of HERV-K genomes exist which differ in the absence (type 1) or the presence (type 2) of a sequence of
292 nucleotides between the putative pol and env genes. Previously published results from teratocarcinoma cell studies
had firmly concluded that the type 1 HERV-K genome was defective in splicing and that only the nondeleted type 2
HERV-K genome containing the 292-nucleotide sequence was capable of being spliced. We now show that in the T47D
human breast tumor cell line it is the type 1 HERV-K genome, and not the type 2, which is spliced to subgenomic
transcripts. q 1997 Academic Press
INTRODUCTION lication (Ono et al., 1986; Lower et al., 1993a,b,1995;
Mueller-Lantzsch et al., 1993; Patience et al., 1996).
Human endogenous retroviral sequences (HERVs)
Lower et al. (1993a,b,1995) have shown that after steroid
which make up an estimated 1.0% of the entire human
hormone treatment of human teratocarcinoma cells Tera
genome are grouped into single and multiple copy fami-
2 and GH, which results in stimulation of the expression
lies and classified according to the tRNA they use as
of the HERV-K genome and production of retroviral-like
primer for reverse transcription (Leib-Mosch et al., 1990).
particles [for which the HERV-K genome codes (Boller et
Although most HERVs seem to be defective due to multi-
al., 1993)], both type 1 and type 2 HERV-K full-length
ple termination codons and deletions (Larsson et al.,
transcripts are present. However, in the teratocarcinoma
1989; Wilkinson et al., 1994) the HERV-K family which was
cells only type 2 transcripts which contain the 292-bp
originally identified by its homology to Mouse Mammary
sequence are spliced to a subgenomic env mRNA and
Tumor Virus (MMTV) and to Syrian Hamster Intercisternal
two smaller messages (Lower et al., 1995).
A-type particles (IAPs) (Ono et al., 1986) contains mem-
Due to the homology of the HERV-K family to MMTV
bers which are full-length proviruses and which are tran-
(Ono et al., 1986; Callahan et al., 1982; Deen and Sweet,
scriptionally active (Ono et al., 1987; Brodsky et al., 1993;
1986; Franklin et al., 1988; May and Westley, 1986), the
Lower et al., 1993a; Patience et al., 1996).
etiological agent of breast cancer in inbred mice (Moore
Four members of the human endogenous retrovirus
et al., 1979), and the fact that certain strains of inbred
HERV-K family (HERV-K8,K10,K18,and K22) were initially
mice develop mammary tumors as a result of the hor-
isolated from a human fetal liver genomic library by hy-
monally activated transcription of endogenous MMTV se-
bridization to sequences encoding the conserved pol re-
quences (Andervont et al., 1940; Michalides et al., 1981;
gion of the Syrian Hamster IAP genome (Ono et al., 1986).
Cohen and Varmus, 1980; Etkind and Sarkar, 1983)
The complete nucleotide sequence of HERV-K10 was
whose endogenous human homologues are the HERV-
determined and shown to be a full-length 9.2-kb provirus
K sequences we have examined the expression of Type
with LTRs at each end (Ono et al., 1986; Ono, 1986).
1 and Type 2 HERV-K genomes in the human breast
HERV-K8 and HERV-K22 were similar, but contained an
tumor cell line T47D (Keydar et al., 1979). In T47D cells
additional 292-bp sequence between the pol and env
as in the teratocarcinoma cells GH and Tera 2, steroid
genes. Recently these two types of HERV-K genomes
hormone treatment stimulates the expression of the
have been designated as either type 1 (missing the 292-
HERV-K genome and the production of retroviral-like par-
bp sequence) or type 2 (containing the 292-bp sequence)
ticles (Keydar et al., 1979,1984; Ono et al., 1987; Faff et
(Lower et al., 1993a,1995).
al., 1992; Seifarth et al., 1995).
To date, HERV-K types 1 and 2 are the only known
human endogenous retroviruses with open reading MATERIALS AND METHODS
frames (ORFs) encoding genes required for retroviral rep-
Cells
The human breast tumor cell line T47D was obtained1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (718)-798-7474. from the American Type Culture Collection (ATCC; Rock-
3040042-6822/97 $25.00
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ville, MD). Cells were grown to near confluency in RPMI
media supplemented with 10% fetal calf serum and 0.2
IU of bovine serum insulin per milliliter and then treated
with 10 nM estradiol for 24 hr followed by addition of 100
nM progesterone for 15 hr to stimulate the expression of
the HERV-K genome (Ono et al., 1987; Keydar et al., 1984).
RT-PCR
Total RNA was isolated from estradiol- and progester-
one-treated T47D cells using the guanidine isothiocya- FIG. 1. Ethidium bromide stained 2% agarose gel electrophoresis of
RT-PCR products. RT RNA from hormone-treated T47D cells was ampli-nate procedure (Chirgwin et al., 1979). RT-PCR was per-
fied in PCR using primers (Fig. 3) specific to the HERV-K U5 regionformed on total RNA by using a Perkin–Elmer–Cetus
and either env(A)(lane 2) or env(B)(lane 1) regions. Far left lane containskit according to the manufacturer’s instructions. RT was commercial DNA molecular weight markers (Gibco/BRL).
carried out for 10 min at 377 and then for 30 min at 427.
For amplification the following cycle scheme was used:
1.0 min at 947, 1.0 min at 547, and 1 min at 727, for 40 6926–6946) and RNA from estradiol- and progesterone-
cycles, and 10 min at 727. In all RNA PCRs no PCR signal treated T47D cells, subcloned into pGEMT Vector (Pro-
could be detected when RT was omitted, excluding the mega), and sequenced.
possibility of contaminating DNA in RNA preparations.
DNA used in PCR reactions was also isolated from hor- Southern blots
mone-treated T47D cells using the guanidine isothiocya-
PCR products were run on 2% agarose gels, detectednate procedure.
under UV light by ethidium bromide staining, and trans-
ferred onto nitrocellulose (Schleicher and Schuell)Primers and probes
(Southern, 1975). DNA was covalently bound to the nitro-
The complete nucleotide sequence of a genomic clone celluose by a UV-Stratalinker (Stratagene). Hybridization
representing HERV-K type 1 was published by Ono et al. was done under stringent conditions in 50% formamide
(1986) and named HERV-K10. For HERV-K type 2 se- as previously described (Etkind and Sarkar, 1983) with
quence information was available for only an additional [g-32P]ATP 5*end-labeled probes made using the RTS T4
292 bp found in the genomic clone K8. Ono et al. (1986) kinase labeling system (GibcoBRL). After hybridization
composed and published a composite sequence which for approximately 48 hr at 427 radiolabeled probe was
he generated by insertion of these additional 292 nucleo- removed and blots were washed in 21 SSC (201 SSC
tides into the HERV-K10 sequence at position 6551 and  3 M NaCl, 0.3 M Nacitrate) and 0.1% SDS for two 15-
designated this composite sequence HERV-K10(/). This min washes at room temperature and then for two 15-
sequence is used for numbering nucleotides in this pa- min washes at 557. The two final washes were in 0.11
per (Ono et al., 1986). SSC in 0.1% SDS at 557 for 15 min each. Hybridizations
Primers. The following primers were synthesized by were analyzed both by X-ray film and in the Phosphor-
the Oligonucleotide Synthesis Facility at the Albert Ein- Imager (Molecular Dynamics).
stein College of Medicine Cancer Center: U5 region of
HERV-K 5*GAGGCTGGCGGGATCCT3* (nt 814–830), and DNA sequencing
(nt 833–853) 5*ATATGCTGAACGCTGGTTCCC3*; env A
Direct sequencing of PCR products including probe(env region) (nt 6926–6946) 5*ATCCTCCTATTTGCCTAG-
P1-env A was done using the Sequenase kit (US Bio-GGA3* and (nt 6949–6969) 5*GCACCAGGATGTTTAATG-
chemicals) and the dideoxynucleotide chain-terminationCCT3*; env B (env region) (nt 8456–8476) 5*GGGCCA-
method (Sanger et al., 1977).TGATGACGATGGCGG3* and (nt 8513–8533) 5*GCA-
AGAGAGATCAAATTGTTA3*; P1 (integrase region) (nt
RESULTS and DISCUSSION6072–6095) 5*CAACAGGAATTCCTTATAATTCCC3* and
P3 (env region) (nt 7958 –7980) 5*CAATCTTGTAGAATT- Analysis of putative subgenomic HERV-K transcripts
CTTTTGCC3*.
Probes. The 95-bp oligonucleotide probe which con- Using primers specific for the U5 region of the HERV-
K genome, nt 814–830, and nt 833–853, and the envtained sequences from nt 6639–6734 within the 292-bp
sequence found in HERV-K Type 2 genomes was also region, designated env(A), nt 6926–6946 and nt 6949–
6969, (Ono et al., 1986, Fig. 3) and reverse-transcribedsynthesized at the Einstein Facility. Probe P1-env A DNA
probe which contained 584 bp from HERV-K nt 6072 – T47D cell RNA we detected a product of 497 bp (Fig. 1,
lane 2) in nested PCR reactions. DNA sequencing of this6500 and from 6790–6946 (missing the 292-bp sequence
between nt 6500 and 6790) was synthesized by RT-PCR 497-bp PCR product revealed a transcript encompassing
the 5* sequences of HERV-K up to a splice donor at ntusing primers P1 and env A (internal primer from nt
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1076, the existence of which had already been postulated
by Ono et al. (1986) to a splice acceptor at nt 6400 (Fig.
3). The sequence downstream of this splice acceptor is
approximately 97% homologous to Ono’s (Ono et al.,
1986) published HERV-K10 sequence [stop codon TAA
at nt 6495–6497 (Ono et al., 1986) is changed to AAA in
our PCR products] and therefore does not contain the
292-bp sequence found between the pol and env regions
of HERV-K type 2 genomes. The putative HERV-K spliced
env mRNA from teratocarcinoma cells reported by Lower
et al. (1993) contains the same splice donor site at nt
1076 but a different splice acceptor at nt 6433 with the
stop codon TAA at nt 6495–6497 changed to AGA. In
FIG. 2. Left panel is an ethidium bromide-stained 2% agarose geladdition the region downstream from nt 6433 beginning
electrophoresis of PCR products derived from: lane 1, RT RNA isolated
at nt 6500 in the teratocarcinoma cell env transcripts from hormone stimulated T47D cells and P1 and P3 primers; lane 2,
contains the 292-bp sequence (Lower et al., 1993). We control PCR (no RT) containing RNA isolated from hormone stimulated
T47D cells and P1 and P3 primers; and lane 3, PCR reaction containinghave sequenced three additional 497-bp products from
T47D cell genomic DNA and P1 and P3 primers. Far left lane containsthree separate PCR reactions from RNA isolated from
DNA molecular weight markers. Right panel is the Southern blot ofthree separate T47D cell preparations and have never
the gel in the left panel hybridized to the radiolabeled 95-bp probe
seen the presence of the 292-bp sequence in any of the representative of nt 6639–6734 (Ono et al., 1986) present in the 292-
sequenced products. Finally, hybridization of the South- bp sequence of type 2 HERV-Ks.
ern blot in Fig. 1 to the radio-labeled 95-bp DNA probe
representative of nt 6639 –6734 in the 292-bp sequence Analysis of putative full-length HERV-K transcripts
found in HERV-K type 2 was negative (not shown).
To discriminate between putative full-length and sub-Using the same U5 primers and primers specific for
genomic env transcripts present in T47D cells we usedHERV-K env (designated env[B]) sequences nt 8456–
primers designated P1, nt 6072–6095 (integrase region
8476 and nt 8513–8533, (Ono et al., 1986, Fig. 3) with
of the pol gene) and P3, nt 7958–7980 (env region) (Ono
reverse-transcribed T47D cell RNA we have detected a
et al., 1986, Fig. 3) which are similar to those used by
PCR product of approximately 311 bp in nested PCR
Lower et al. (1995). This primer pair will only amplify
reactions (Fig. 1, lane 1). Sequencing revealed a tran-
cDNA derived from full-length transcripts because the
script containing the 5* sequences of HERV-K up to the sequences to which the P1 primer binds in the gag/pol
splice donor site at nt 1076 to a splice acceptor site at intron are spliced out in subgenomic env mRNAs. Using
nt 8408 (Fig. 3). This sequenced 311-bp product was these primers (P1,P3) the products generated by RT-PCR
approximately 98% homologous to Ono’s published should comprise 1908 nt when the transcripts are derived
HERV-K10 sequence (Ono et al., 1986). As described from type 2 proviral sequences and 1616 nt when the
above, hybridization of the 311-bp PCR product on South- transcripts are derived from type 1 proviral genomes
ern blots to the 95-bp probe representing sequences (Lower et al., 1995).
found in the 292-bp sequence found in HERV-K type 2 PCR using primers P1 and P3 and RT-RNA isolated
was negative. An mRNA spliced at the same splice donor from hormone-treated T47D cells revealed a band at
and splice acceptor sites as this 311-bp PCR product 1616 bp and a faint band at 1908 (Fig. 2, left panel, lane
is also seen in the teratocarcinoma cells (Lower et al., 1). PCR performed on T47D cell genomic DNA produced
1993a). two readily visible bands at 1616 and 1908 bp; the 1616-
In addition, the teratocarcinoma cells contain a doubly bp product being more abundant (Fig. 2, left panel, lane
spliced mRNA which has one splice donor at nt 1076 3). Hybridization of the Southern blot of the gel in the left
and splice acceptor at nt 6433 and a second splice donor panel to the radio-labeled 95-bp probe representative of
at nt 6708 and a second splice aceptor at nt 8408 which sequences present in the 292-bp sequence determined
contains 208 bp of the 292-bp sequence found in type 2 that the 1908-bp fragment does contain sequences pres-
HERV-Ks. This 208-bp sequence encodes a short open ent in the 292-bp region present in type 2 HERV-Ks while
reading frame (ORF) for a small protein of approximately the 1616-bp fragment does not (Fig. 2, right panel, lanes
12 kDa which accumulates in the nucleolus of teratocar- 1 and 3). DNA sequencing confirmed the hybridization
cinoma cells (Lower et al., 1995). We have never seen results.
this doubly spliced mRNA in T47D cells. Therefore, unlike To determine the relative abundance of type 1 and type
the data reported for teratocarcinoma cell lines, HERV- 2 HERV-K transcripts in the spliced and unspliced RNA
K-spliced transcripts produced under hormonal stimula- pools the Southern blot of lane 1, left panel, of Fig. 2,
tion of the T47D cell line do not contain the 292-bp se- was hybridized with the P1-env A probe representative of
HERV-K sequences from the integrase region of the polquence found in HERV-K type 2 genomes.
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FIG. 3. (A) HERV-K genome with Spliced Donor (SD) and Splice Acceptor (SA) sites and regions denoting specific DNA primers (, ). Also
shown are the open reading frames for gag, prt, pol, and env genes and the 292-nucleotide sequence between the pol and env genes which is
present in type 2 HERV-K genomes(Ono et al., 1986; Lower et al., 1993a, b). (B) RT-PCR products resulting from the specific primers (, ) shown
in (A). Closely spaced dots represent PCR products, separated dashes represent spliced out regions. None of the RT-PCR products depicted contain
the 292-bp region.
gene, nt 6072–6500, and env region sequences, nt 6790– lated T47D cells we have detected the presence of both
type 1 and type 2 putative full-length transcripts, with a6946, excluding the 292-bp sequence between the pol
and env region (Fig. 4). PhosphorImager analysis of the 10-fold excess of full-length type 1 over type 2, and the
presence of only type 1 putative subgenomic transcripts.number of counts under the peak of each hybridized band
as shown in Fig. 4 revealed a 10-fold (peak B  320,440 Although previous reports have strongly argued that
HERV-K type 1 genomes are defective in env splicingcounts) excess of the type 1 1616-bp transcript to the type
2 (peak A  32,048 counts) 1908-bp transcript. These and may require the 292-bp sequence for splicing to
occur (Lower et al., 1995), our results in T47D cells clearlyexperiments which were repeated by varying PCR condi-
tions (quantity of input cDNA and number of cycles) and show that the HERV-K type 1 genome is not defective in
env splicing. Therefore, in the T47D human breast tumorusing RNA from different T47D preparations gave repro-
ducible results of an approximate 10-fold excess of HERV- cell line the type 1 HERV-K genome, in which the pol
and env genes are fused, is able to undergo splicing toK type 1 transcripts to type 2 when analyzed in the phos-
phorImager. Similarly Lower et al. (1995) also found both subgenomic transcripts.
type 1 and type 2 transcripts in teratocarinoma cells with
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